Rituximab

Various toxicities: case report

    Reactions Weekly volume 1838, page476(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Casertano S, et al. Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodies. European Journal of Neurology 27: 2673-2675, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1111/ene.14498

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Rituximab. Reactions Weekly 1838, 476 (2021). https://doi.org/10.1007/s40278-021-89793-5

    Download citation